• Share
• Email

• Share
• Email

Ipca Laboratories Ltd. is involve into manufacture and distribution of pharmaceutical formulations and active pharmaceutical ingredients. The company has plants located at Madhya Pradesh, Gujarat, Dadra and Nagar Haveli, Maharashtra and Uttarkhand. The company has posted a net profit for the period Q3 (ending Dec 09) of the current fiscal (FY10). During the said quarter, net profit rose 151.29% to Rs 58.25 crores in comparison to the Rs 23.18 crores profit of Q3 (ending Dec 08) of previous year(FY09).

The company informed the market(BSE) that the net sales increased 26.62% to Rs 393.92 crores in Q3 FY10 when compared with the same quarter Q3 FY09 of previous year. Net sales was Rs 311.10 crores in last year’s same quarter.

Share’s Data :
BSE Code : 524494
Mkt. Cap: Rs 3035 Crores
P/E Ratio: 32.40
EPS (Rs): 36.50
Face Value : Rs 10
Last Dividend : 40% in Jan 2010
52 Week H/L : Rs 1299.00 / 285.05
Ipca Laboratories Ltd. share’s CMP is Rs 1204.45 on 22nd Jan 2010.

Related posts:

1. Tera Software Q3 FY10 Results : Net up 12.16% Tera Software Pvt Ltd. is a Hyderabad based integrated IT...
2. Unity Infraprojects Q3 FY10 Results : Net up 38.24% Unity Infraprojects is a construction company and main activities of...
3. JSW Energy Q3 FY10 Results : Net up 54.13% JSW Energy Ltd.(JSWEL) a group company of JSW group headed...
4. Nilkamal Q3 FY10 Results : Net zooms to Rs 16.76 crores Nilkamal Ltd. is a company to manufacture injection Moulded Plastic...
5. Biocon Q3 FY10 Results : Net up 173.26% Biocon Ltd. is involve into manufacture biotechnological products through fermentation...

Related posts brought to you by Yet Another Related Posts Plugin.